Lack of Correlation of Hypoxic Cell Fraction and Angiogenesis with Glucose Metabolic Rate in NonSmall Cell Lung Cancer Assessed by 18F-Fluoromisonidazole and 18F-FDG PET
Martin H. Cherk1,
Serene S. Foo2,
Aurora M.T. Poon1,
Simon R. Knight3,
Carmel Murone2,
Anthony T. Papenfuss4,
John I. Sachinidis1,
Timothy H.C. Saunder1,
Graeme J. O'Keefe1 and
Andrew M. Scott1,2,5
1 Centre for PET, Austin Hospital, Heidelberg, Victoria, Australia; 2 Ludwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia; 3 Department of Thoracic Surgery, Austin Hospital, Heidelberg, Victoria, Australia; 4 Division of Bioinformatics, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia; and 5 Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia

View larger version (29K):
[in this window]
[in a new window]
|
FIGURE 1. 18F-FDG and 18F-FMISO PET scans in patient 12. (A) Intense uniform 18F-FDG uptake in tumor. (B) 18F-FMISO uptake in tumor similar to that of blood pool.
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIGURE 2. 18F-FDG and 18F-FMISO PET scans in patient 15. (A) Intense uniform 18F-FDG uptake in tumor. (B) Heterogeneous mildly increased 18F-FMISO uptake with more prominent uptake in periphery of tumor.
|
|

View larger version (67K):
[in this window]
[in a new window]
|
FIGURE 3. IHC of tumor biopsies from 2 representative patients. (Top row) Moderately differentiated squamous cell carcinoma (patient 12) with high 18F-FDG uptake and minimal 18F-FMISO uptake on PET studies. (Bottom row) Moderately differentiated adenocarcinoma (patient 15) in which expression of all tumor markers was similar despite higher 18F-FMISO uptake on PET studies. (GLUT1, HIF-1 , VEGF, and Ki67, x400; VWF, x200)
|
|
Copyright © 2006 by the Society of Nuclear Medicine.